Subcutaneous Vedolizumab Appears to Be Effective Maintenance Therapy in Crohns Disease
NEW YORK (Reuters Health) – Subcutaneous vedolizumab appears to be an effective and safe maintenance therapy for some patients with
Read moreNEW YORK (Reuters Health) – Subcutaneous vedolizumab appears to be an effective and safe maintenance therapy for some patients with
Read more(Reuters Health) – Children with Hirschsprung disease may be at increased risk for developing inflammatory bowel disease, a Canadian study
Read moreNon-Medical Switching (NMS) is the act of compelling a stable patient to change medications for reasons other than their health
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART MELOXICAM CAPSULES Capsules Meloxicam Consumer Medicine
Read more